Investment Summary

Polaris Partners Invests In Thirty Madison

On August 4, 2020, growth capital firm Polaris Partners invested in healthcare services company Thirty Madison

Investment Highlights
  • This is Polaris Partners’ 4th transaction in the Healthcare Services sector.
  • This is Polaris Partners’ 58th transaction in the United States.
  • This is Polaris Partners’ 12th transaction in New York.

Investment Summary
Date 2020-08-04
Target Thirty Madison
Sector Healthcare Services
Investor(s) Polaris Partners
Deal Type Venture

Target

Thirty Madison

New York, New York, United States
Thirty Madison makes specialized care and clinically-proven treatments accessible and affordable for everyone by bringing the specialist experience directly into people's homes with online doctor consultations, treatment delivery, and ongoing support. The company prioritizes and enables the cultivation of meaningful doctor-patient relationships to provide the best care for successful management of lifelong conditions. Thirty Madison was formed in 2017 and is based in New York.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Polaris Partners

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1996
PE ASSETS 5.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.

DEAL STATS #
Overall 62 of 87
Sector (Healthcare Services) 4 of 4
Type (Venture) 34 of 57
State (New York) 12 of 13
Country (United States) 58 of 78
Year (2020) 6 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-07-09 VICO Therapeutics

Leiden, Netherlands

Vico Therapeutics is developing therapies for rare neurological diseases, leveraging RNA modifying technologies. VICO Therapeutics was founded in 2019 and is based in Leiden, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-01 Noema

Basel, Switzerland

Noema is developing therapies to restore functioning in patients with orphan conditions of the brain and nervous system. Noema was founded in 2019 and is based in Basel, Switzerland.

Buy -
Mergr

Product

Company

Legal